Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FXGZU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,331.60 by the Defense Logistics Agency on September 3, 2025, for the supply of Nexplanon 68 mg implants. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million through November 2026 under the SPE2DB program.
The Defense Logistics Agency utilizes this IDC vehicle to procure a comprehensive portfolio of pharmaceutical products supporting medical supply requirements across military healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a demonstrated portfolio of contract awards covering branded and generic prescription drugs, biologics, medical consumables, and specialized pharmaceutical products. The Nexplanon implant delivery under this order supports the agency's broader mission to provide pharmaceutical and medical supplies to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FXGZU?
SPE2DB25FXGZU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FXGZU worth?
The government has obligated $8,332 on SPE2DB25FXGZU.
Is contract SPE2DB25FXGZU an order under another contract?
Yes. SPE2DB25FXGZU is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB25FXGZU competed?
The extent of competition for SPE2DB25FXGZU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award